Tenax Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire November 25, 2025 CHAPEL HILL, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will present at the following […]
Rubico Inc. Announces Time Charter Extensions and Contracted Revenue Backlog of $120.8 Million GlobeNewswire November 25, 2025 ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (NASDAQ: RUBI) (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today that it entered into agreements with the time charterer of
Purespring Therapeutics to Present at Piper Sandler's 37th Annual Healthcare Conference GlobeNewswire November 25, 2025 Purespring Therapeutics to Present at Piper Sandler's 37th Annual Healthcare Conference London – 25 November 2025 – Purespring Therapeutics, a precision nephrology company leading the development of targeted, first-in-class genetic therapies to preserve kidney function, today announced that members of
Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update GlobeNewswire November 25, 2025 AMX-883 shows synergistic efficacy in combination with venetoclax in vivo and prevents the emergence of resistance to venetoclax in vitro, addressing a major clinical challenge in acute myeloid leukaemia
Airtory Partners with CultureSync Media to Elevate Rich Media Advertising Across Hong Kong, Taiwan, and Singapore GlobeNewswire November 25, 2025 LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Airtory, a dynamic creative management platform specializing in immersive and high-performing rich media advertising, today announced a strategic partnership with CultureSync Media, a marketing agency specializing in culturally
Generic Drug CRO Market Size to Climb to USD 11.73 Billion by 2034, reports Towards Healthcare The global generic drug CRO market size was valued at USD 8.45 billion in 2024 and is predicted to hit around USD 11.73 billion by 2034, rising at a 3.36% CAGR, a study published by Towards Healthcare a sister
Upstream Bio to Participate in Upcoming December Investor Conferences GlobeNewswire November 25, 2025 WALTHAM, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will
According to MarketsandMarkets™,The pet biotics market is estimated at USD 878.1 million in 2025 and is projected to reach USD 1,232.5 million by 2030, at a CAGR of 7.0% from 2025 to 2030. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg The global pet biotics market is expanding rapidly as pet owners increasingly prioritize digestive health, immunity, and overall wellness for their
CHICAGO and MILWAUKEE and NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs announced distributions for the YieldMax(R) Group 1 weekly pay ETFs. Group 1 Distribution Announcement Ex. & Record Date: November 26, 2025Payment Date: November 28, 2025 ETFTicker1 ETF Name DistributionFrequency Distribution perShare DistributionRate2,4 30-DaySEC Yield3 ROC5 CHPY YieldMax(R) Semiconductor Portfolio Option Income
— Major investment cements Canadian leadership in AI, quantum, and next-generation connectivity while driving sustainable growth and world-class talent development. — Project showcases the strength ofNokia's strategic partnerships with the Government of Canada, Government of Ontario and City of Ottawa. Today marks a bold new era for Canadian innovation as Nokia breaks ground on its